Published in CMAJ on December 18, 2008
Estimating the number of coronary artery bypass graft and percutaneous coronary intervention procedures in Canada: a comparison of cardiac registry and Canadian Institute for Health Information data sources. Can J Cardiol (2010) 0.93
Are drug-eluting stents safe in the long term? CMAJ (2008) 0.82
Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: a Canadian experience. Can J Cardiol (2010) 0.79
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med (2002) 12.84
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med (2004) 11.86
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol (2006) 8.27
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol (2006) 6.07
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation (2004) 5.44
Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med (2006) 5.39
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med (2007) 4.95
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet (2003) 4.68
Coronary-artery stents. N Engl J Med (2006) 4.13
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45
Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med (2008) 3.29
Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation (2003) 3.22
Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med (1996) 2.95
Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol (2005) 2.90
Overview of the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease. On behalf of the APPROACH investigators. Can J Cardiol (2000) 2.83
Evidence for use of coronary stents. A hierarchical bayesian meta-analysis. Ann Intern Med (2003) 2.79
The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol (2004) 2.78
TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation (2003) 2.74
Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med (2007) 2.50
Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med (2006) 2.42
Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med (2006) 2.38
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation (2004) 2.35
Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol (2007) 2.11
Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA (2004) 2.02
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation (2007) 1.85
Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol (2006) 1.57
Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort. Am Heart J (2001) 1.55
Dealing with missing data in observational health care outcome analyses. J Clin Epidemiol (2000) 1.49
Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Circulation (2006) 1.25
Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation (2004) 1.17
Very late thrombosis after drug-eluting stents. Catheter Cardiovasc Interv (2006) 0.98
An administrative data merging solution for dealing with missing data in a clinical registry: adaptation from ICD-9 to ICD-10. BMC Med Res Methodol (2008) 0.92
Drug-eluting stent update 2007: part II: Unsettled issues. Circulation (2007) 0.82
Very late bare-metal stent thrombosis. A case report and review of the literature. J Invasive Cardiol (2006) 0.77
Very late thrombosis after sirolimus-eluting stent implantation. J Cardiovasc Med (Hagerstown) (2006) 0.77
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care (2005) 30.41
The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ (2004) 21.24
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology (2011) 12.09
Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2007) 7.79
New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol (2004) 7.20
D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med (2004) 6.15
Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ (2011) 6.11
Validity of information on comorbidity derived rom ICD-9-CCM administrative data. Med Care (2002) 5.92
Physician wellness: a missing quality indicator. Lancet (2009) 5.50
Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care (2004) 5.12
Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med (2006) 4.90
Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res (2008) 4.25
Validity of procedure codes in International Classification of Diseases, 9th revision, clinical modification administrative data. Med Care (2004) 4.15
The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials (2002) 3.62
Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis (2003) 3.60
Survival after coronary revascularization in the elderly. Circulation (2002) 3.17
Chelation therapy for ischemic heart disease: a randomized controlled trial. JAMA (2002) 3.13
Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis (2002) 3.06
Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med (2007) 3.06
Dealing with missing data in a multi-question depression scale: a comparison of imputation methods. BMC Med Res Methodol (2006) 2.81
The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol (2004) 2.78
Validation of a case definition to define hypertension using administrative data. Hypertension (2009) 2.74
Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol (2005) 2.69
An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol (2004) 2.58
Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke (2005) 2.50
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol (2004) 2.32
Hospital and surgeon determinants of carotid endarterectomy outcomes. Arch Neurol (2002) 2.30
Cardiac rehabilitation attendance and outcomes in coronary artery disease patients. Circulation (2012) 2.30
Effectiveness of interventions targeting frequent users of emergency departments: a systematic review. Ann Emerg Med (2011) 2.19
Development of a frailty index for patients with coronary artery disease. J Am Geriatr Soc (2010) 2.18
Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care (2007) 2.14
Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol (2012) 2.11
Outcomes after aortic and mitral valve replacement surgery in Canada: 1994/95 to 1999/2000. Can J Cardiol (2004) 2.11
Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg (2007) 2.06
Coronary revascularization for patients with severe left ventricular dysfunction. Ann Thorac Surg (2013) 2.06
Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. Circulation (2006) 2.05
Sex differences in access to coronary revascularization after cardiac catheterization: importance of detailed clinical data. Ann Intern Med (2002) 2.03
Overview of a formal scoping review on health system report cards. Implement Sci (2010) 1.95
Access to health care among status Aboriginal people with chronic kidney disease. CMAJ (2008) 1.91
Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation (2011) 1.85
Association of socio-economic status with diabetes prevalence and utilization of diabetes care services. BMC Health Serv Res (2006) 1.80
Sex differences in outcomes after cardiac catheterization: effect modification by treatment strategy and time. JAMA (2004) 1.79
Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med (2008) 1.76
Development and validation of a surname list to define Chinese ethnicity. Med Care (2006) 1.71
Quality of life after coronary revascularization in the elderly. Eur Heart J (2006) 1.66
Multiple imputation versus data enhancement for dealing with missing data in observational health care outcome analyses. J Clin Epidemiol (2002) 1.65
Variation in health services utilization among ethnic populations. CMAJ (2006) 1.64
Population rates of cardiac catheterization and yield of high-risk coronary artery disease. CMAJ (2005) 1.64
Assessing accuracy of diagnosis-type indicators for flagging complications in administrative data. J Clin Epidemiol (2004) 1.62
Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol (2006) 1.58
The Enhancing Secondary Prevention in Coronary Artery Disease trial. CMAJ (2009) 1.57
Cardiovascular fitness and mortality after contemporary cardiac rehabilitation. Mayo Clin Proc (2013) 1.56
Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2011) 1.55
Women with coronary artery disease report worse health-related quality of life outcomes compared to men. Health Qual Life Outcomes (2004) 1.53
Accuracy of city postal code coordinates as a proxy for location of residence. Int J Health Geogr (2004) 1.52
Venous thromboembolic disease: comparison of the diagnostic process in blacks and whites. Arch Intern Med (2003) 1.51
Public versus private institutional performance reporting: what is mandatory for quality improvement? Am Heart J (2006) 1.50
Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int (2010) 1.50
Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm (2011) 1.48
Relation of T-axis abnormalities to coronary artery disease and survival after cardiac catheterization. Am J Cardiol (2005) 1.48
Exploring the treatment-risk paradox in coronary disease. Arch Intern Med (2007) 1.48
Prevalence of chronic kidney disease and survival among aboriginal people. J Am Soc Nephrol (2007) 1.47